HEMAVANT Trademark

Trademark Overview


On Thursday, March 16, 2023, a trademark application was filed for HEMAVANT with the United States Patent and Trademark Office. The USPTO has given the HEMAVANT trademark a serial number of 97842014. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Tuesday, October 17, 2023. This trademark is owned by Roivant Sciences GmbH. The HEMAVANT trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations for human use for the treatment of hematological and bleeding diseases, disorders and conditions; biologic preparations for medical and therapeutic purposes for the treatment of hematological and bleeding diseases, disorders and conditions

Providing health and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions

Scientific and technological services, namely, medical research, scientific research and analysis, and diagnostic services in the field of hematology and bleeding diseases, disorders and conditions; pharmaceutical and biomedical research services; research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical research and development; providing scientific research information in the field of pharmaceuticals and biomedicine; Conducting clinical trials for others relating to pharmaceutical preparations and biologic preparations; conducting post-authorization pharmaceutical research for use in the marketing of pharmaceutical preparations and biologic preparations and evaluating epidemiological results
hemavant

General Information


Serial Number97842014
Word MarkHEMAVANT
Filing DateThursday, March 16, 2023
Status645 - FINAL REFUSAL - MAILED
Status DateTuesday, October 17, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the stylized wording "HEMAVANT" with a design of a partially filled droplet in place of the first "A".
Goods and ServicesPharmaceutical preparations for human use for the treatment of hematological and bleeding diseases, disorders and conditions; biologic preparations for medical and therapeutic purposes for the treatment of hematological and bleeding diseases, disorders and conditions
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesProviding health and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions
Goods and ServicesScientific and technological services, namely, medical research, scientific research and analysis, and diagnostic services in the field of hematology and bleeding diseases, disorders and conditions; pharmaceutical and biomedical research services; research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical research and development; providing scientific research information in the field of pharmaceuticals and biomedicine; Conducting clinical trials for others relating to pharmaceutical preparations and biologic preparations; conducting post-authorization pharmaceutical research for use in the marketing of pharmaceutical preparations and biologic preparations and evaluating epidemiological results

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 6, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 6, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 6, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRoivant Sciences GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBasel 4051
CH

Trademark Events


Event DateEvent Description
Tuesday, January 16, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, January 16, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, October 17, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, October 17, 2023FINAL REFUSAL E-MAILED
Tuesday, October 17, 2023FINAL REFUSAL WRITTEN
Monday, September 18, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 18, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 18, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 29, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 29, 2023NON-FINAL ACTION E-MAILED
Thursday, June 29, 2023NON-FINAL ACTION WRITTEN
Wednesday, May 31, 2023ASSIGNED TO EXAMINER
Friday, April 7, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, April 6, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 20, 2023NEW APPLICATION ENTERED